Skip to main content
. 2023 Dec 10;15(12):e50297. doi: 10.7759/cureus.50297

Table 5. Correlation between serum OSM expression and the AIS prognosis.

n (%) applies to the amount of each outcome and M (Q1, Q3) applies to the respective 90-day mRS score and serum OSM level.

AIS: acute ischemic stroke; OSM: oncostatin M; mRS: modified Rankin scale

  Amount (%) 90-day mRS score Serum OSM pg/ml Z-score P-value
Favorable outcome 79 (58.96%) 1.00 (0.00, 2.00) 216.70 (181.70, 258.30) 0.083 0.492
Unfavorable outcome 55 (41,04%) 4.00 (3.00, 6.00) 221.98 (181.30, 261.10)